BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week
10. Januar 2025 08:00 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
BullFrog AI Issues Letter to Stockholders
27. Dezember 2024 08:00 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
BullFrog AI Announces Appointment of Chief Financial Officer
17. Dezember 2024 16:30 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
BullFrog AI’s VP Artificial Intelligence to Present at Google’s Cancer AI Symposium
22. Oktober 2024 07:30 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Oct. 22, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million
21. Oktober 2024 11:45 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial...
Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million
18. Oktober 2024 09:30 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Oct. 18, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial...
BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni
15. Oktober 2024 07:30 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114
09. Oktober 2024 07:30 ET
|
BullFrog AI Holdings, Inc.
The study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCCThe findings suggest that...
BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
26. August 2024 08:00 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced today that the...
BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets
25. Juli 2024 07:30 ET
|
BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., July 25, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced significant...